11/15
08:04 am
avbp
ArriVent BioPharma, Inc. (NASDAQ: AVBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $36.00 price target on the stock.
Medium
Report
ArriVent BioPharma, Inc. (NASDAQ: AVBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $36.00 price target on the stock.
9/11
12:17 pm
avbp
Rating for AVBP
Medium
Report
Rating for AVBP
9/11
12:17 pm
avbp
Rating for AVBP
Medium
Report
Rating for AVBP
9/10
12:10 pm
avbp
ArriVent BioPharma, Inc. (NASDAQ: AVBP) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $39.00 price target on the stock, up previously from $35.00.
Low
Report
ArriVent BioPharma, Inc. (NASDAQ: AVBP) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $39.00 price target on the stock, up previously from $35.00.
9/10
11:22 am
avbp
Rating for AVBP
Low
Report
Rating for AVBP
9/10
11:22 am
avbp
Rating for AVBP
Low
Report
Rating for AVBP
9/10
09:54 am
avbp
Rating for AVBP
Medium
Report
Rating for AVBP
9/10
09:54 am
avbp
Rating for AVBP
Medium
Report
Rating for AVBP
9/10
09:54 am
avbp
Rating for AVBP
Medium
Report
Rating for AVBP